ACCUSTEM SCIENCES, INC.

ACUT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Assets
Cash & Equivalents
Accounts Receivable
Inventory
Total Current Assets $137.4K $47.8K $129.8K $252.6K $452.7K $240.8K $932.0K $1.6M
Property, Plant & Equipment $2.2K $3.1K $4.0K $5.0K $5.9K $6.8K $7.7K $8.6K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $139.7K $50.9K $133.9K $257.6K $458.5K $247.6K $939.7K $1.6M
Liabilities
Accounts Payable $744.7K $649.5K $578.4K $432.4K $382.8K $307.1K $311.8K $154.9K
Total Current Liabilities $3.0M $2.7M $2.2M $2.1M $1.8M $1.2M $1.1M $824.9K
Long-Term Debt
Total Liabilities $3.0M $2.7M $2.2M $2.1M $1.8M $1.2M $1.1M $824.9K
Stockholders' Equity
Retained Earnings $-7.3M $-7.0M $-6.5M $-6.3M $-5.7M $-5.3M $-4.5M $-3.5M
Total Stockholders' Equity $-2.9M $-2.6M $-2.1M $-1.9M $-1.3M $-946.7K $-139.6K $797.7K
← Newer Page 2 of 3 Older →